A previous study observed that in liver samples from patients with obesity with insulin resistance and NAFLD, the mRNA expression of SLC13A5 was significantly increased, and was correlated with hepatic steatosis [33]. Here, SLC13A5 is linked to metabolic dysfunction-associated steatotic liver disease.